Clark E. Tedford

2.0k total citations
48 papers, 1.6k citations indexed

About

Clark E. Tedford is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Clark E. Tedford has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Clark E. Tedford's work include Laser Applications in Dentistry and Medicine (16 papers), Mast cells and histamine (11 papers) and Receptor Mechanisms and Signaling (10 papers). Clark E. Tedford is often cited by papers focused on Laser Applications in Dentistry and Medicine (16 papers), Mast cells and histamine (11 papers) and Receptor Mechanisms and Signaling (10 papers). Clark E. Tedford collaborates with scholars based in United States, Switzerland and China. Clark E. Tedford's co-authors include Rob Leurs, H. Timmerman, Patrizio Blandina, Ying‐Ying Huang, Michael R. Hamblin, Kazuya Nagata, Juanita J. Anders, Steven L. Jacques, Thomas J. McCarthy and Stephen L. Yates and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Brain Research.

In The Last Decade

Clark E. Tedford

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clark E. Tedford United States	20	601	553	491	350	187	48	1.6k
Paul Polak United States	29	876 1.5×	194 0.4×	256 0.5×	335 1.0×	39 0.2×	58	2.3k
Xavier Gasull Spain	27	1.3k 2.2×	126 0.2×	111 0.2×	631 1.8×	336 1.8×	74	2.9k
Lorraine A. DeGiorgio United States	18	807 1.3×	442 0.8×	678 1.4×	460 1.3×	20 0.1×	31	2.6k
J Cermák United States	22	272 0.5×	248 0.4×	125 0.3×	209 0.6×	78 0.4×	32	1.7k
Roopa S. Ghirnikar United States	13	961 1.6×	60 0.1×	355 0.7×	761 2.2×	39 0.2×	17	2.6k
Fumihiko Okada Japan	19	642 1.1×	197 0.4×	107 0.2×	256 0.7×	22 0.1×	48	1.4k
Ch. Owman Sweden	18	717 1.2×	76 0.1×	177 0.4×	496 1.4×	49 0.3×	44	1.7k
Nico Melzer Germany	28	545 0.9×	53 0.1×	397 0.8×	430 1.2×	132 0.7×	99	2.5k
Kenneth G. Haglid Sweden	28	1.3k 2.1×	76 0.1×	133 0.3×	478 1.4×	55 0.3×	90	2.4k
Jesse D. Sengillo United States	21	1.1k 1.7×	213 0.4×	72 0.1×	284 0.8×	29 0.2×	74	2.4k

Countries citing papers authored by Clark E. Tedford

Since Specialization

Citations

This map shows the geographic impact of Clark E. Tedford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clark E. Tedford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clark E. Tedford more than expected).

Fields of papers citing papers by Clark E. Tedford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clark E. Tedford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clark E. Tedford. The network helps show where Clark E. Tedford may publish in the future.

Co-authorship network of co-authors of Clark E. Tedford

This figure shows the co-authorship network connecting the top 25 collaborators of Clark E. Tedford. A scholar is included among the top collaborators of Clark E. Tedford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clark E. Tedford. Clark E. Tedford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valter, Krisztina, Stephanie E. Tedford, Janis T. Eells, & Clark E. Tedford. (2024). Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside. SHILAP Revista de lepidopterología. 4. 1388602–1388602. 7 indexed citations

Burton, Ben, Maurízio Battaglia Parodi, Ignasi Jürgens, et al.. (2023). LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration. Ophthalmology and Therapy. 12(2). 953–968. 28 indexed citations

Kaymak, Hakan, Marion R. Munk, Stephanie E. Tedford, et al.. (2023). Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System. Clinical ophthalmology. Volume 17. 3549–3559. 9 indexed citations

Tedford, Clark E., et al.. (2021). Improvement of Visual Function following Multi-wavelength Photobiomodulation with the Valeda Light Delivery System on Electroretinography (ERG) and Best Corrected Visual Acuity (BCVA) in Dry Age-related Macular Degeneration in the ELECTROLIGHT Study (Interim Analysis). 62(8). 233–233. 1 indexed citations

Yu, Zhanyang, Zhaoyu Li, Ning Liu, et al.. (2015). Near infrared radiation protects against oxygen-glucose deprivation-induced neurotoxicity by down-regulating neuronal nitric oxide synthase (nNOS) activity in vitro. Metabolic Brain Disease. 30(3). 829–837. 13 indexed citations

Huang, Ying‐Ying, Kazuya Nagata, Clark E. Tedford, & Michael R. Hamblin. (2013). Low‐level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro. Journal of Biophotonics. 7(8). 656–664. 86 indexed citations

Huang, Ying‐Ying, Kazuya Nagata, Clark E. Tedford, Thomas J. McCarthy, & Michael R. Hamblin. (2012). Low‐level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro. Journal of Biophotonics. 6(10). 829–838. 181 indexed citations

Herrold, Amy A., Fei Shen, Martin P. Graham, et al.. (2008). Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug and Alcohol Dependence. 99(1-3). 231–239. 39 indexed citations

McDaid, John, et al.. (2006). Nullifying drug-induced sensitization: Behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats. Drug and Alcohol Dependence. 86(1). 55–66. 28 indexed citations

10.

Yates, Stephen L., et al.. (1999). Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex. Biochemical Pharmacology. 57(9). 1059–1066. 16 indexed citations

11.

Tedford, Clark E., et al.. (1998). Pharmacological characterization of GT-2331, a new CNS-penetrating high affinity histamine H3 receptor antagonist. The Society for Neuroscience Abstracts. 24. 1838. 1 indexed citations

12.

Phillips, James G., et al.. (1998). Development of a sensitive and quantitative analytical method for 1H-4-substituted imidazole histamine H3-receptor antagonists utilizing high-performance liquid chromatography and dabsyl derivatization. Journal of Chromatography B Biomedical Sciences and Applications. 716(1-2). 239–249. 7 indexed citations

13.

Leurs, Rob, Patrizio Blandina, Clark E. Tedford, & H. Timmerman. (1998). Therapeutic potential of histamine H3 receptor agonists and antagonists. Trends in Pharmacological Sciences. 19(5). 177–184. 237 indexed citations

14.

Tedford, Clark E., Marcel Hoffmann, Nahid Seyedi, et al.. (1998). High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models. European Journal of Pharmacology. 351(3). 307–311. 41 indexed citations

15.

Tephly, Thomas R., Birgit L. Coffman, Gladys R. Rios, et al.. (1994). Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.. Drug Metabolism and Disposition. 22(5). 713–718. 5 indexed citations

16.

Tedford, Clark E., Vicki L. Coffin, Vilma Ruperto, et al.. (1993). Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in rats. Psychopharmacology. 113(2). 199–204. 10 indexed citations

17.

Tedford, Clark E., Gordon Crosby, Louis C. Iorio, & Richard E. Chipkin. (1992). Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. European Journal of Pharmacology. 211(2). 169–176. 17 indexed citations

18.

McQuade, Robert D., et al.. (1992). Highlights of D1 dopamine receptor antagonist research. Neurochemistry International. 20. 119–122. 14 indexed citations

19.

Tedford, Clark E., et al.. (1988). Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.. Journal of Pharmacology and Experimental Therapeutics. 247(2). 460–465. 2 indexed citations

20.

Tedford, Clark E., et al.. (1988). Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.. Journal of Pharmacology and Experimental Therapeutics. 247(2). 640–644. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact